Found: 22
Select item for more details and to access through your institution.
Bioorthogonal Probes for the Study of MDM2-p53 Inhibitors in Cells and Development of High-Content Screening Assays for Drug Discovery.
- Published in:
- Angewandte Chemie, 2016, v. 128, n. 52, p. 16260, doi. 10.1002/ange.201608568
- By:
- Publication type:
- Article
Bioorthogonal Probes for the Study of MDM2-p53 Inhibitors in Cells and Development of High-Content Screening Assays for Drug Discovery.
- Published in:
- Angewandte Chemie International Edition, 2016, v. 55, n. 52, p. 16026, doi. 10.1002/anie.201608568
- By:
- Publication type:
- Article
A distinct p53 target gene set predicts for response to the selective p53-HDM2 inhibitor NVP-CGM097.
- Published in:
- eLife, 2015, p. 1, doi. 10.7554/eLife.06498
- By:
- Publication type:
- Article
p53 dynamics vary between tissues and are linked with radiation sensitivity.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-21145-z
- By:
- Publication type:
- Article
Total Synthesis and Biological Evaluation of a C(10)/C(12)-Phenylene-Bridged Analog of Epothilone D.
- Published in:
- Chemistry & Biodiversity, 2004, v. 1, n. 11, p. 1771, doi. 10.1002/cbdv.200490133
- By:
- Publication type:
- Article
Optimization of a Class of Dihydrobenzofurane Analogs toward Orally Efficacious YAP‐TEAD Protein‐Protein Interaction Inhibitors.
- Published in:
- ChemMedChem, 2023, v. 18, n. 11, p. 1, doi. 10.1002/cmdc.202300051
- By:
- Publication type:
- Article
Front Cover: The First Class of Small Molecules Potently Disrupting the YAP‐TEAD Interaction by Direct Competition (ChemMedChem 19/2022).
- Published in:
- ChemMedChem, 2022, v. 17, n. 19, p. 1, doi. 10.1002/cmdc.202200514
- By:
- Publication type:
- Article
The First Class of Small Molecules Potently Disrupting the YAP‐TEAD Interaction by Direct Competition.
- Published in:
- ChemMedChem, 2022, v. 17, n. 19, p. 1, doi. 10.1002/cmdc.202200303
- By:
- Publication type:
- Article
Front Cover: Structural States of Hdm2 and HdmX: X‐ray Elucidation of Adaptations and Binding Interactions for Different Chemical Compound Classes (ChemMedChem 14/2019).
- Published in:
- ChemMedChem, 2019, v. 14, n. 14, p. 1304, doi. 10.1002/cmdc.201900400
- By:
- Publication type:
- Article
Structural States of Hdm2 and HdmX: X‐ray Elucidation of Adaptations and Binding Interactions for Different Chemical Compound Classes.
- Published in:
- ChemMedChem, 2019, v. 14, n. 14, p. 1305, doi. 10.1002/cmdc.201900201
- By:
- Publication type:
- Article
9‐epi‐Artemisinin – How a Single Stereo Center Affects Chemical Reactivity under Reductive Conditions.
- Published in:
- Helvetica Chimica Acta, 2022, v. 105, n. 5, p. 1, doi. 10.1002/hlca.202100230
- By:
- Publication type:
- Article
Synthesis of Modified Tripeptides and Tetrapeptides as potential bisubstrate inhibitors of the epidermal growth factor receptor protein tyrosine kinase.
- Published in:
- Helvetica Chimica Acta, 1997, v. 80, n. 3, p. 653, doi. 10.1002/hlca.19970800304
- By:
- Publication type:
- Article
Selective in vivo and in vitro effects of a small molecule inhibitor of cyclin-dependent kinase 4.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Molecular and structural characterization of a TEAD mutation at the origin of Sveinsson's chorioretinal atrophy.
- Published in:
- FEBS Journal, 2019, v. 286, n. 12, p. 2381, doi. 10.1111/febs.14817
- By:
- Publication type:
- Article
Cover Picture: The TEAD4-YAP/TAZ Protein-Protein Interaction: Expected Similarities and Unexpected Differences (ChemBioChem 10/2013).
- Published in:
- ChemBioChem, 2013, v. 14, n. 10, p. 1149, doi. 10.1002/cbic.201390033
- By:
- Publication type:
- Article
The TEAD4-YAP/TAZ Protein-Protein Interaction: Expected Similarities and Unexpected Differences.
- Published in:
- ChemBioChem, 2013, v. 14, n. 10, p. 1218, doi. 10.1002/cbic.201300163
- By:
- Publication type:
- Article
Tyrosine kinase inhibitors: From rational design to clinical trials.
- Published in:
- Medicinal Research Reviews, 2001, v. 21, n. 6, p. 499, doi. 10.1002/med.1022
- By:
- Publication type:
- Article
Selective GRB2 SH2 inhibitors as anti-Ras therapy.
- Published in:
- International Journal of Cancer, 1999, v. 83, n. 2, p. 235, doi. 10.1002/(SICI)1097-0215(19991008)83:2<235::AID-IJC15>3.0.CO;2-B
- By:
- Publication type:
- Article
A new perspective on the interaction between the Vg/VGLL1-3 proteins and the TEAD transcription factors.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-74584-x
- By:
- Publication type:
- Article
Study of the cytotoxic effect of a peptidic inhibitor of the p53–hdm2 interaction in tumor cells
- Published in:
- FEBS Letters, 2002, v. 529, n. 2/3, p. 293, doi. 10.1016/S0014-5793(02)03362-8
- By:
- Publication type:
- Article
Identification of FAM181A and FAM181B as new interactors with the TEAD transcription factors.
- Published in:
- Protein Science: A Publication of the Protein Society, 2020, v. 29, n. 2, p. 509, doi. 10.1002/pro.3775
- By:
- Publication type:
- Article
Adaptation of the bound intrinsically disordered protein YAP to mutations at the YAP:TEAD interface.
- Published in:
- Protein Science: A Publication of the Protein Society, 2018, v. 27, n. 10, p. 1810, doi. 10.1002/pro.3493
- By:
- Publication type:
- Article